Should I buy or sell Privia Health Group stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRVA shares. View PRVA analyst ratings or view top-rated stocks .

What is Privia Health Group's stock price target for 2024?

9 equities research analysts have issued 1-year price objectives for Privia Health Group's stock. Their PRVA share price targets range from $26.00 to $41.00. On average, they predict the company's stock price to reach $34.64 in the next year. This suggests a possible upside of 56.7% from the stock's current price. View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts .

How have PRVA shares performed in 2023?

Privia Health Group's stock was trading at $22.71 at the start of the year. Since then, PRVA stock has decreased by 2.7% and is now trading at $22.10. View the best growth stocks for 2023 here .

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our PRVA earnings forecast .

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) released its quarterly earnings results on Friday, November, 3rd. The company reported $0.05 EPS for the quarter, hitting the consensus estimate of $0.05. The business earned $417.30 million during the quarter, compared to the consensus estimate of $410.51 million. Privia Health Group had a trailing twelve-month return on equity of 6.80% and a net margin of 2.40%. The firm's revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.01 earnings per share.

What ETFs hold Privia Health Group's stock?

ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC) , Invesco S&P SmallCap Health Care ETF (PSCH) , SPDR S&P Health Care Services ETF (XHS) , BNY Mellon Innovators ETF (BKIV) , ROBO Global Healthcare Technology and Innovation ETF (HTEC) , Fidelity Disruptive Medicine ETF (FMED) , First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and Franklin Genomic Advancements ETF (HELX) .

When did Privia Health Group IPO?

(PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair served as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Who are Privia Health Group's major shareholders?

Privia Health Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include FMR LLC (12.09%), Bank of New York Mellon Corp (3.44%), Riverbridge Partners LLC (3.40%), Principal Financial Group Inc. (2.99%), Invesco Ltd. (1.46%) and Avidity Partners Management LP (1.31%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle , Jeffrey B Butler, Jeffrey Daniel Bernstein , Matthew Shawn Morris , Pamplona Capital Partners Iii,, Parth Mehrotra , Thomas Bartrum and William M Sullivan . View institutional ownership trends .

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Privia Health Group Stock Price, News & Analysis (NASDAQ:PRVA)

$22.10

+0.16 (+0.73%)

(As of 11/28/2023 ET)

Compare

Today's Range: $21.57
▼
$22.25
50-Day Range: $20.42
▼
$23.65
52-Week Range: $19.68
▼
$30.15

Volume: 485,460 shs
Average Volume: 1.13 million shs
Market Capitalization: $2.61 billion

P/E Ratio: 71.29
Dividend Yield: N/A
Price Target: $34.64

Privia Health Group MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 56.7% Upside
$34.64 Price Target
Short Interest: Bearish
6.63% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.93
Based on 2 Articles This Week
Insider Trading: Selling Shares
$1.32 M Sold Last Quarter
Proj. Earnings Growth: 45.45%
From $0.22 to $0.32 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.74 out of 5 stars

Medical Sector

165th out of 949 stocks

Health Services Industry

3rd out of 12 stocks

3.5

Analyst's Opinion

Consensus Rating
Privia Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $34.64, Privia Health Group has a forecasted upside of 56.7% from its current price of $22.10.
Amount of Analyst Coverage
Privia Health Group has only been the subject of 1 research reports in the past 90 days.

1.0

Short Interest

Percentage of Shares Shorted
6.63% of the float of Privia Health Group has been sold short.
Short Interest Ratio / Days to Cover
Privia Health Group has a short interest ratio ("days to cover") of 7.2.
Change versus previous month
Short interest in Privia Health Group has recently increased by 1.66%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Privia Health Group does not currently pay a dividend.
Dividend Growth
Privia Health Group does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PRVA.

2.7

News and Social Media Coverage

News Sentiment
Privia Health Group has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Privia Health Group this week, compared to 2 articles on an average week.
Search Interest
Only 1 people have searched for PRVA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
7 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 75% compared to the previous 30 days.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,321,248.00 in company stock.
Percentage Held by Insiders
44.80% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
92.40% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Privia Health Group are expected to grow by 45.45% in the coming year, from $0.22 to $0.32 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Privia Health Group is 71.29, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 121.66.
Price to Earnings Ratio vs. Sector
The P/E ratio of Privia Health Group is 71.29, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 130.93.
Price to Earnings Growth Ratio
Privia Health Group has a PEG Ratio of 2.86. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Privia Health Group has a P/B Ratio of 4.88. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Privia Health Group Stock (NASDAQ:PRVA)

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

PRVA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PRVA Stock News Headlines

November 24, 2023 | morningstar.com

Privia Health Group Inc

November 19, 2023 | americanbankingnews.com

Privia Health Group (NASDAQ:PRVA) Given New $38.00 Price Target at JPMorgan Chase & Co.

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

November 6, 2023 | finance.yahoo.com

Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2023 Earnings Call Transcript

November 5, 2023 | seekingalpha.com

Privia Health Group, Inc. 2023 Q3 - Results - Earnings Call Presentation

November 4, 2023 | finance.yahoo.com

Privia Health Group, Inc.'s (NASDAQ:PRVA) P/S Still Appears To Be Reasonable

November 4, 2023 | finance.yahoo.com

Q3 2023 Privia Health Group Inc Earnings Call